期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Cancer and comorbidity:The role of leptin in breast cancer and associated pathologies 被引量:1
1
作者 amitabha ray 《World Journal of Clinical Cases》 SCIE 2018年第12期483-492,共10页
Obesity is an important risk factor for postmenopausal breast cancer and also a poor prognostic factor among cancer patients. Moreover, obesity is associated with a number of health disorders such as insulin resistanc... Obesity is an important risk factor for postmenopausal breast cancer and also a poor prognostic factor among cancer patients. Moreover, obesity is associated with a number of health disorders such as insulin resistance/type-2 diabetes mellitus, hypertension, and other cardiovascular diseases. Frequently, these health disorders exhibit as components/complications of the metabolic syndrome. Nevertheless, obesity-related diseases may coexist with postmenopausal breast cancer; and these comorbid conditions could be substantial. Therefore, it may be assumed that different diseases including breast cancer could originate from a common pathological background in excessive adipose tissue. Adipocyte-released hormone-like cytokine(or adipokine) leptin behaves differently in a normal healthy state and obesity. A growing body of evidence suggests an important role of leptin in our major obesity-related health issues such as insulin resistance, hypertension, and neoplasia. In this context, this review describes the relationships of the abovementioned pathologies with leptin. 展开更多
关键词 Hypertension OBESITY POSTMENOPAUSAL breast CANCER COMORBIDITY Diabetes
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部